<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Dimova, Ivanka</dc:creator>
  <dc:creator>Raicheva, Sashka</dc:creator>
  <dc:creator>Dimitrov, Rumen</dc:creator>
  <dc:creator>Doganov, Nikolai</dc:creator>
  <dc:creator>Toncheva, Draga</dc:creator>
  <dc:date>2009-06-20</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: We selected 5 oncogenes with well-established roles in carcinogenesis – CCND1, ErbB1, ErbB2, c-mycand ZNF217– to investigate the coexistence of their copy imbalances in relation to the clinico-pathological characteristics of ovarian tumors. Materials and Methods: Fluorescence in situ hybridization for the 5 genes was applied to a preexisting tissue microarray. 38 ovarian tumors were successfully analyzed for copy number changes of the 5 genes. Results: At least one of these oncogenes was gained/amplified in 27 out of 38 tumors (71.1). We report the highest frequency of c-mycgenetic gain/amplification since it affected 42.1 of the ovarian tumors. We observed sequential involvement of copy number alterations of the other genes in the presence of c-mycdisruption. The incidence of copy number changes of the 5 oncogenes – both single and combinatorial – was higher in high-grade tumors. All double aberrations in the serous group comprised c-mycand ZNF217copy number increases. Conclusions: Our results revealed a combination between copy number increases of c-mycand ZNF217, associated with serous histology. The data from this combined analysis of the 5 oncogenes could be used as a basis in considering the combined approach in molecular-based therapy of ovarian cancer.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/301873</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/301873/files/dim_ccn.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1159/000219368</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Onkologie. - 2009, vol. 32, no. 7, p. 405-410</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Ovarian cancer</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Oncogenes</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Genomic imbalances</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Fluorescence in situ hybridization</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Coexistence of copy number increases of c-Myc, ZNF217, CCND1, ErbB1 and ErbB2 in ovarian cancers</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
